New and Generic Drug Approvals
October 21, 2014
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Effexor Xr | venlafaxine hydrochloride | Capsule, Extended Release;Oral | Wyeth Pharms Inc | Labeling Revision |
| Flomax | tamsulosin hydrochloride | Capsule;Oral | Boehringer Ingelheim | Labeling Revision |
| Paricalcitol | paricalcitol | Injectable;Injection | Hospira Inc | Approval |
| Saphris | asenapine maleate | Tablet;Sublingual | Forest Labs Inc | Labeling Revision |
| Topamax | topiramate | Tablet;Oral | Janssen Pharms | Labeling Revision |
| Topamax | topiramate | Capsule;Oral | Janssen Pharms | Labeling Revision |
| Topamax Sprinkle | topiramate | Capsule;Oral | Janssen Pharms | Labeling Revision |
No comments:
Post a Comment